A- A A+

USA. NIDA Director: Opioid Overdose ED Patients Need Access to Tx

Discharging opioid or heroin overdose patients from the emergency department (ED) without connecting them to treatment options “should be considered malpractice,” according to the director of the National Institute on Drug Abuse (NIDA).

Research has shown that one in 10 people who come to an ED because of an opioid or heroin overdose die within a year, said Nora Volkow, MD, Wednesday at the National Rx Drug Abuse and Heroin Summit in Atlanta. (ATForum, USA, 06.04.2018)

http://atforum.com/2018/04/nida-director-opioid-overdose-ed-patients-access-tx/

Kanada. B.C. allows nurses to prescribe opioid substitutes, lowering barriers to treatment and clean alternative to street drugs

Nurse practitioners can now offer patients hydromorphone, an opioid similar to heroin that can help people addicted to drugs who failed with more traditional treatments. (The Georgia Straight, Kanada, 04.04.2018)

https://www.straight.com/news/1053306/bc-allows-nurses-prescribe-opioid-substitutes-lowering-barriers-treatment-and-clean

USA. The Wrong Way to Treat Opioid Addiction

(...) Only about one-third of American addiction programs offer what many experts worldwide see as the standard of care — long-term use of either methadone or buprenorphine. Most programs view medication as a crutch for short-term use and provide only talk therapies. (MAIA SZALAVITZ in: New York Times, Opinion, 17.01.2018)

https://www.nytimes.com/2018/01/17/opinion/treating-opioid-addiction.html

Factors affecting the dose of methadone among patients receiving methadone maintenance therapy in Taiwan.

Li DJ, Chung KS, Wu HC, Hsu CY, Yen CF.

Am J Addict. 2018 Apr;27(3):225-230. doi: 10.1111/ajad.12712.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29569392

USA. FDA to broaden access to medication-assisted treatment for opioid addiction

The Food and Drug Administration expects to roll out guidance on expanded access to opioid addiction therapy known as medication-assisted treatment, Health and Human Services Secretary Alex Azar announced Saturday at a meeting of the National Governor's Association.

As a practice, such treatment utilizes behavioral therapy as well as medications like buphrenorphine and methadone that can reduce cravings and withdrawal symptoms from opioid use. Many addiction specialists consider it the gold standard of addiction treatment.

"Medication-assisted treatment works. The evidence on this is voluminous and ever-growing," Azar said. (CNN, 26.02.2018)

https://edition.cnn.com/2018/02/26/health/medication-assisted-treatment-opioid-azar/index.html

Concurrent drug use among methadone maintenance patients in mountainous areas in northern Vietnam.

Tran BX, Boggiano VL, Thi Nguyen HL, Nguyen LH, Nguyen HV, Hoang CD, Le HT, Tran TD, Le HQ, Latkin CA, Thi Vu TM, Zhang MW, Ho RC.

BMJ Open. 2018 Mar 22;8(3):e015875. doi: 10.1136/bmjopen-2017-015875.

http://bmjopen.bmj.com/content/8/3/e015875.long

An investigation of an open-access model for scaling up methadone maintenance treatment.

Madden LM, Farnum SO, Eggert KF, Quanbeck AR, Freeman R, Ball SA, Schottenfeld RS, Shi JM, Savage ME, Barry DT.

Addiction. 2018 Feb 17. doi: 10.1111/add.14198.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29453891

Service providers' adherence to methadone maintenance treatment protocol in China.

Lin C, Lan CW, Li L, Rou K.

Int J Drug Policy. 2018 Mar 9;56:1-5. doi: 10.1016/j.drugpo.2018.02.018.

https://www.ncbi.nlm.nih.gov/pubmed/29529449

Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental illness.

Parpouchi M, Moniruzzaman A, Rezansoff SN, Russolillo A, Somers JM.

Addict Behav Rep. 2017 Sep 23;6:106-111. doi: 10.1016/j.abrep.2017.09.001.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800549/

Perceptions and practices addressing diversion among US buprenorphine prescribers.

Lin LA, Lofwall MR, Walsh SL, Gordon AJ, Knudsen HK.

Drug Alcohol Depend. 2018 Mar 10;186:147-153. doi: 10.1016/j.drugalcdep.2018.01.015.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29573649

Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?

Kurdyak P, Jacob B, Zaheer J, Fischer B.

Can Fam Physician. 2018 Feb;64(2):e95-e103.

http://www.cfp.ca/content/64/2/e95.long

USA. Federal Ban on Methadone Vans Seen as Barrier to Treatment

From California to Vermont, mobile methadone vans have served people with opioid addiction in rural towns and underserved inner-city neighborhoods for nearly three decades.

But the U.S. Drug Enforcement Administration, which regulates dispensing of the FDA-approved addiction medicine, has refused to license any new methadone vans since 2007 over concerns about potential diversion of the medication.

Now, in an unrelenting opioid epidemic that is killing more than a hundred Americans every day, some state and local addiction agencies are asking the federal government to lift its moratorium as quickly as possible. (The Pew Charitable Trusts, USA, 23.03.2018)

http://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2018/03/23/federal-ban-on-methadone-vans-seen-as-barrier-to-treatment

Experiences of substance abusers from methadone maintenance therapy.

Shamsalinia A, Norouzi K, Fallahi-Khoshknab M, Farhoudian A, Ghaffari F.

Med J Islam Repub Iran. 2017 Aug 12;31:45. doi: 10.14196/mjiri.31.45.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804444/

Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville).

Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, et al. (2014) Methadone

PLoS ONE 9(11): e112328. doi.org/10.1371/journal.pone.0112328

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0112328

Caring for Ms. L. - Overcoming My Fear of Treating Opioid Use Disorder.

Provenzano AM.

N Engl J Med. 2018 Feb 15;378(7):600-601. doi: 10.1056/NEJMp1715093.

http://www.nejm.org/doi/full/10.1056/NEJMp1715093

USA. New opioid treatment model increases efficiency

Drug overdose is the leading cause of accidental death in the U.S., according to the American Society of Addiction Medicine. The open-access treatment model, developed and implemented by a team of Yale researchers, has the potential to become a key component of treatment for people addicted to opioids. (Yale News, 27.02.2018)

https://yaledailynews.com/blog/2018/02/27/new-opioid-treatment-model-increases-efficiency/

Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.

Holland, R., Maskrey, V., Swift, L., Notley, C., Robinson, A., Nagar, J., Gale, T. and Kouimtsidis, C. (2014),

Addiction, 109: 596–607. doi:10.1111/add.12439

Abstract

http://onlinelibrary.wiley.com/doi/10.1111/add.12439/abstract

Alcohol and tobacco use among methadone maintenance patients in Vietnamese rural mountainside areas.

Tran BX, Nguyen HLT, Le QNH, Mai HT, Ngo C, Hoang CD, Nguyen HH, Le HQ, Van Nguyen H, Le HT, Tran TD, Zary N, Latkin CA, Vu TMT, Ho RCM, Zhang MWB.

Addict Behav Rep. 2017 Nov 20;7:19-25. doi: 10.1016/j.abrep.2017.11.005.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29450252

Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.

Li ZB, Zhang L, Wang J, Huang LP, Zhou ZR, Cao YN, Zhao M, Du J.

Harm Reduct J. 2017 Nov 2;14(1):71. doi: 10.1186/s12954-017-0197-3.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667515/

Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam.

Vuong T, Ritter A, Shanahan M, Ali R, Nguyen N, Pham K, Vuong TTA, Le GM.

J Subst Abuse Treat. 2018 Apr;87:9-15. doi: 10.1016/j.jsat.2018.01.011.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29471930

Evaluation of Methadone Treatment in Malaysia: Findings from the Malaysian Methadone Treatment Outcome Study (MyTOS).

Ali N, Aziz SA, Nordin S, Mi NC, Abdullah N, Paranthaman V, Mahmud M, Yee A, Danaee M.

Subst Use Misuse. 2018 Jan 28;53(2):239-248. doi: 10.1080/10826084.2017.1385630.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29116878

Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.

Makarenko I, Mazhnaya A, Marcus R, Pykalo I, Madden L, Filippovich S, Dvoriak S, Altice FL.

J Subst Abuse Treat. 2018 Apr;87:1-8. doi: 10.1016/j.jsat.2018.01.007.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29471921